CB
JAZZ icon

CNB Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

CNB Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6
Closed -$739 – 505
2024
Q4 		$739 Hold
6
– – ﹤0.01% 470
2024
Q3 		$668 Hold
6
– – ﹤0.01% 501
2024
Q2 		$640 Hold
6
– – ﹤0.01% 494
2024
Q1 		$723 Hold
6
– – ﹤0.01% 480
2023
Q4 		$738 Hold
6
– – ﹤0.01% 468
2023
Q3 		$777 Buy
6
+5
+500% +$666 ﹤0.01% 476
2023
Q2 		$124 Buy
+1
New +$135 ﹤0.01% 437

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

CNB Bank's JAZZ Position: Q1 2025 in Review

CNB Bank sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2025, closing a stake of 6 shares — an estimated $739 sold.

CNB Bank first reported a position in JAZZ in Q2 2023 and held it in 7 quarters. The position peaked at $777 in Q3 2023. 550 funds tracked by Wall St. Rank hold JAZZ as of Q1 2025.

  • CNB Bank reported no remaining Jazz Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • CNB Bank sold 6 Jazz Pharmaceuticals shares in Q1 2025, an estimated $739.
  • CNB Bank first reported a position in Jazz Pharmaceuticals in Q2 2023 and held it in 7 quarters.
  • CNB Bank's Jazz Pharmaceuticals position peaked at $777 in Q3 2023.
  • 550 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2025.

Based on CNB Bank's 13F filing for Q1 2025, filed 24 Apr 2025.